Literature DB >> 20333352

Should we administer sildenafil to patients with acute respiratory distress syndrome? No.

Silvio A Namendys-Silva, Marisol Hernández-Garay, Eduardo Rivero-Sigarroa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20333352     DOI： 10.1007/s00134-010-1865-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  7 in total

Review 1.  Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.

Authors:  Shahzad G Raja; Mark D Danton; Kenneth J MacArthur; James C Pollock
Journal:  J Cardiothorac Vasc Anesth       Date:  2006-04-05       Impact factor: 2.628

2.  Is right ventricular function the one that matters in ARDS patients? Definitely yes.

Authors:  Antoine Vieillard-Baron
Journal:  Intensive Care Med       Date:  2008-10-07       Impact factor: 17.440

3.  Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

4.  Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS.

Authors:  Alexander D Cornet; Jorrit J Hofstra; Eleonora L Swart; Armand R J Girbes; Nicole P Juffermans
Journal:  Intensive Care Med       Date:  2010-02-04       Impact factor: 17.440

5.  Incidence and prognostic value of right ventricular failure in acute respiratory distress syndrome.

Authors:  David Osman; Xavier Monnet; Vincent Castelain; Nadia Anguel; Josiane Warszawski; Jean-Louis Teboul; Christian Richard
Journal:  Intensive Care Med       Date:  2008-10-07       Impact factor: 17.440

Review 6.  ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

Authors:  Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga; Robert A Harrington; Jeffrey L Anderson; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Cindy L Grines; Mark A Hlatky; Alice K Jacobs; Sanjay Kaul; Robert C Lichtenberg; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Gerald M Pohost; Robert S Rosenson; Richard S Schofield; Samuel J Shubrooks; James H Stein; Cynthia M Tracy; Howard H Weitz; Deborah J Wesley
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

Review 7.  Sildenafil: a review of its use in pulmonary arterial hypertension.

Authors:  Katherine F Croom; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.